Research and Markets: OTC Analgesics Have Yet to Benefit from Concerns about Prescription Pain Relievers - OTC Analgesics in the United States.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c23273) has announced the addition of OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). Analgesics Analgesics Definition Analgesics are medicines that relieve pain. Purpose Analgesics are those drugs that mainly provide pain relief. in the United States to their offering. Sales of OTC internal analgesics declined 11% between 1999 and 2004 or 21% at constant 2004 dollars in FDM (1) (Fused Deposition Modeling) See 3D printing. (2) (Frequency Division Multiplexing) Transmitting multiple data signals simultaneously over a single wire by using multiple carriers, each having a unique center frequency. channels (not including Wal-Mart). However, the category had over $2.1 billion in sales in 2004. At least part of the shrinkage of the OTC analgesics market since 1999 is due to growth in prescription "COX-2 inhibitor cox-2 inhibitor: see nonsteroidal anti-inflammatory drug. " drugs such as Celebrex and Vioxx. These drugs were approved by the Federal Drug Administration (FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ) in 1998 and 1999, respectively. They appeal to customers looking for effective treatment for arthritis pain without the potential upset stomach that aspirin and other prostaglandin-blockers can cause. The past two years have brought many issues related to the safety of OTC analgesics to light. Among them are studies that show many Americans tend to overuse overuse Health care The common use of a particular intervention even when the benefits of the intervention don't justify the potential harm or cost–eg, prescribing antibiotics for a probable viral URI. Cf Misuse, Underuse. these types of products, as well as some well-publicized incidences of harmful consequences of OTC pain reliever usage. COX-2 inhibitors and/or prescription NSAIDS, have come under fire in the past year due to claims of serious and often fatal side effects. The drug Vioxx, a Merck drug used to alleviate arthritis symptoms, was pulled from the market in September 2004, and in April 2005, the FDA asked Pfizer to voluntarily remove Bextra from the market. OTC analgesics have yet to benefit from concerns about prescription pain relievers. The internal analgesic analgesic (ăn'əljē`zĭk), any of a diverse group of drugs used to relieve pain. Analgesic drugs include the nonsteroidal anti-inflammatory drugs (NSAIDs) such as the salicylates, narcotic drugs such as morphine, and synthetic drugs industry can be segmented into two parts, based on delivery system. Tablets (which include caplets, capsules, and gelcaps, enterics, dissolvables, and chewables) comprise the larger segment, accounting for more than 90% of sales. Liquids account for the remainder. Companies Mentioned: McNeil Consumer & Specialty Pharmaceuticals Wyeth Consumer Healthcare Bayer Consumer Care Bristol-Myers Squibb For more information visit http://www.researchandmarkets.com/reports/c23273 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion